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1. main messages
Diet and exercise interventions can be reasonably cost-effective but are insufficient to substantially reduce •	
the burden due to overweight and obesity.
In order to address the growing problem of obesity, there is an urgent need to assess the (cost-)•	
effectiveness of interventions that change the ‘obesogenic’ environment and target populations rather 
than individuals.
 
2. background
Overweight and obesity in adults is a global public health concern because excess weight increases the risk 
of disease and mortality. A range of highly prevalent diseases, notably cardiovascular disease, diabetes and a 
number of cancers, have been proven to be directly related to excess weight. In 2004/2005, 62% of Australian 
men and 45% of women were classified as overweight or obese. High body mass was responsible for loss of 
almost 200,000 DALYs in Australia in 2003, which was 7.5% of the total burden of disease and injury.
 
3. interventions
Interventions to reduce overweight and obesity can be divided into those that target individuals and those 
that target the ‘obesogenic’ environment in which people live. Interventions that target adults individually 
mostly consist of advice and support to improve diet and increase physical activity levels, with or without 
the simultaneous use of weight-reducing drugs. There is generally less evidence on the effectiveness of 
environmental interventions, partly because this evidence is more difficult to gather. Based on the literature we 
selected four interventions for cost-effectiveness analysis:
low-fat diet:1.  This diet was developed in New Zealand and emphasizes reducing fat intake, while 
maintaining adequate levels of micro and macro-nutrients. Participants in the one year program 
participated in education about reducing dietary fat intake, personal goal setting, self-monitoring and 
evaluation through a series of monthly small group meetings with dieticians. Targeted at overweight and 
obese Australian adults; recruitment via mass media and postal mailings.
diet and exercise: 2. The Dietary Approaches to Stop Hypertension (DASH) programme was developed in 
the US. It emphasizes consumption of fruit, vegetables, low fat dairy products, whole grains, poultry, fish 
and nuts and the reduced consumption of fats, red meat, sweets and sugar containing beverages, and 
recommends 180 minutes per week of moderate intensity physical activity. The programme consists of 10 
group based and 2 individual meetings with dieticians and 2 group meetings and 2 individual meetings 
with exercise physiologists over a 6 month period. Participants also kept food diaries, recorded physical 
activity and monitored food intake. Targeted at overweight and obese Australian adults; recruitment via 
mass media and postal mailings.
orlistat: 3. Lipase inhibitor which aids weight loss by preventing the digestion and absorption of dietary 
fat. Recruitment and prescribing via opportunistic screening by GPs. We assumed a maximum treatment 
duration of one year. Targeted at obese Australian adults.
sibutramine: 4. Aids weight loss by suppressing appetite and increasing metabolism. Recruitment and 
prescribing via opportunistic screening by GPs. We assumed a maximum treatment duration of one year. 
Targeted at obese Australian adults.
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4. cHoice of comparator
All interventions were compared to current practice, which approximates a “do nothing” scenario.
  
5. intervention cost-effectiveness
All four interventions mostly fall in the north-east quadrant of the cost-effectiveness plane and deliver health at a net cost (Figure 1). 
Most of the points for the low-fat diet and diet & exercise interventions fall below the $50,000/DALY threshold. 
Figure 1. Cost-effectiveness of interventions to reduce overweight and obesity
When compared to current practice, the low-fat diet and the diet and exercise interventions are likely to be reasonably cost-effective 
with median costs per DALY of around $30,000 to $40,000 (Table 1). However, when participants’ costs for time and travel are 
included, these ratios increase to $180,000/DALY for the diet and exercise intervention and $130,000/DALY for the low-fat diet and the 
interventions would no longer be considered cost-effective. Treating obese individuals with orlistat or sibutramine is not cost-effective. 
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Table 1 Number of DALYs averted, cost-effectiveness ratio and probability of being cost-effective for the four interventions to reduce 
overweight and obesity when compared to current practice
The estimated impact for these four interventions combined is about 11,000 DALYs over the lifetime of all adult Australians alive in 2003. 
Compared to the total annual loss of 200,000 DALYs due to overweight and obesity, this is a very small effect.
 
 
6. conclusions
Diet and exercise interventions can be reasonably cost-effective but are insufficient to substantially reduce the burden due to 
overweight and obesity. Treating obese persons with orlistat or sibutramine is not cost-effective. The uptake of both drugs and diets is 
likely to be greater among women with higher socio-economic status. Shortages of dieticians and exercise physiologists may limit the 
capacity for diet and exercise interventions, especially in rural areas. 
 
To address the high burden due to excess body weight, there is an urgent need to assess the (cost-)effectiveness of interventions that 
change the ‘obesogenic’ environment and target populations rather than individuals. 
 
As part of the ACE Prevention project, work on nutrition labelling, taxing unhealthy foods and gastric banding is reported elsewhere.
For more information on this topic area, please visit: www.sph.uq.edu.au/bodce-ace-prevention
DALYs averted Cost per DALY (95% uncertainty range) 
Probability of being 
under $50,000/DALY 
Diet & exercise 
2,100 
(310 – 7,600) 
$33,000 
($7,000 – $69,000) 
84% 
Low-fat diet 
1,200 
(110 – 6,100) 
$41,000 
($0 – $310,000) 
59% 
Sibutramine 
5,800 
(4,300 – 7,600) 
$230,000 
($170,000 – $330,000) 
0% 
Orlistat
2,100 
(1,500 – 2,900) 
$700,000 
($500,000 – $1,000,000) 
0% 
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7. about ace-prevention
To aid priority setting in prevention, the Assessing Cost-Effectiveness in Prevention Project (ACE-Prevention) applies 
standardised evaluation methods to assess the cost-effectiveness of 100 to 150 preventive interventions, taking a health 
sector perspective. This information is intended to help decision makers move resources from less efficient current 
practices to more efficient preventive action resulting in greater health gain for the same outlay.
indigenous population results 
1.   Cardiovascular disease prevention 
2.   Diabetes prevention 
3.   Screening and early treatment of chronic kidney disease
overall results 
1.   League table 
2.   Combined effects 
General population results 
1.    Adult depression 
2.    Alcohol 
3.    Blood pressure and cholesterol lowering 
4.    Cannabis 
5.    Cervical cancer screening, Sunsmart and PSA screening 
6.    Childhood mental disorders 
7.    Fruit and vegetables 
8.    HIV 
9.    Obesity 
10.  Osteoporosis 
11.   Physical activity 
12.   Pre diabetes screening 
13.   Psychosis 
14.   Renal replacement therapy, screening and early treatment of chronic kidney disease 
15.   Salt 
16.   Suicide prevention 
17.   Tobacco 
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methods: 
A.   The ACE-Prevention project 
B.   ACE approach to priority setting 
C.   Key assumptions underlying the economic analysis 
D.   Interpretation of ACE-Prevention cost-effectiveness results 
E.   Indigenous Health Service Delivery 
